US: +1 646-781-8004 | Europe:+44-203-868-8738 | APAC:+91-744-778-0008

 sales@meticulousresearch.com

Rapid Diagnostics Market

Release date:

May-2022

Region:

global

Research Code:MRHC - 104553

Sku:MRHC - 104553

Rapid Diagnostics Market by Product (Kits [OTC, Professional], Readers), Platform (Lateral Flow, Serological, PCR), Application (Blood Glucose, Infectious Diseases, Pregnancy, Drugs of Abuse), End User (Hospitals, Diagnostic Labs, Home Care) - Global Forecast to 2029

  • Report ID: MRHC - 104553
  • Pages: 260
  • May-2022
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours
COVID-19

This report provides pre & post COVID-19 market estimates.

The Rapid Diagnostics Market is expected to grow at a CAGR of 1.4% from 2022–2029 to reach $26.4 billion by 2029. A rapid diagnostic test (RDT) is a medical diagnostic test that provides diagnostic results efficiently and immediately (within 1 hour) while the patient is still at the health facility, screening site, or other health care provider.

RDT kits are widely used in hospitals and clinical laboratories for the qualitative and quantitative detection of specific antigens, antibodies, and genetic material or proteins associated with a specific health condition or disease, helping to uncover the underlying mechanisms of disease and enabling doctors and healthcare workers to make crucial medical decisions.

The growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, and emerging technological innovations are the key factors driving the growth of the global rapid diagnostics market.

Rapid Diagnostics Market

Click here to: Get Sample Pages of this Report  

Impact of COVID-19 on the Rapid Diagnostics Market

The COVID-19 pandemic positively impacted that rapid diagnostics market in terms of revenue; however, the pandemic negatively impacted the sales of routine testing kits used mainly to screen cancer, blood glucose, cardiac markers, lipid profile, cholesterol, and other infectious diseases.

The COVID-19 pandemic led to a reduction in the number of overall diagnostic testing conducted globally due to the lockdowns and restrictions imposed by several governments worldwide, which translated further into reduced instrument installations and reduced sales of reagents and consumables; however, the loss of sales occurred in routine testing kits was compensated by high sales of COVID-19-related tests.

Governments worldwide depended on rapid diagnostic kits to screen COVID-19 infections within the population. Also, various governments took numerous initiatives to support the testing needs of their respective countries. Some of them are listed below:

  • In April 2021, the federal government of Germany made it mandatory for employers in Germany to offer free COVID-19 self-testing kits once a week to employees not working from home.
  • In April 2021, the U.K. Government announced its plans to design a system of COVID-19 passports that will allow people to people to attend public events, including sports games, by either showing proof of vaccination or a recent negative test. The Government also announced its plans to provide free test kits through local pharmacy stores, community centers, and home delivery services.
  • In March 2021, The German Federal Ministry of Health approved the sale of COVID-19 rapid antigen tests in supermarket chains, drug stores, pharmacies, and e-commerce websites. For this purpose, Germany's Federal Institute for Drugs and Medical Devices (BfArM) provided special approval to seven COVID-19 rapid antigen test kits for home use.
  • In March 2021, Becker's Healthcare published that the U.S. government is set to launch a national testing strategy to control the spread of COVID-19. Through this testing strategy, the Government will open four COVID-19 testing hubs across the country with an investment of $650 million. These testing hubs were aimed at increasing the number of monthly national testing by 25 million.
  • In October 2020, the Italian Health Ministry announced its plans to conduct rapid COVID-19 diagnostics tests throughout the country to control the rising prevalence of COVID-19 infections.

Despite the supply and logistics challenges due to the COVID-19 pandemic, numerous rapid diagnostics products were launched to fulfill the demand for COVID-19 infection diagnosis in both symptomatic and asymptomatic people. In addition, to align themselves with the travel restrictions, companies operating in the market started to hold web meetings and webinars to interact with their customer and shareholders and provide product descriptions, customer demonstrations, and applications training.

Furthermore, countries worldwide have started to relax lockdown restrictions due to the lower number of new infections and the growing number of people with COVID-19 vaccinations, which is expected to propel the number of routine tests globally. Thus, the COVID-19 pandemic negatively impacted the sale of routine testing kits globally; however, high sales of COVID-19-related tests compensated for the loss of sales in routine testing kits.

Key Findings in the Global Rapid Diagnostics Market Study:

Kits segment Generated Larger Proportion of Revenue Compared to Test Readers/Analysers

The kits segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment can be attributed to the rising adoption and repetitive kits usage. In addition, the growing portfolio of disease-specific kits for the early diagnosis of chronic diseases and the increasing technological advancements are other factors supporting the growth of this segment.

Immunoassays to Dominate the Market

The immunoassays segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is mainly attributed to the increasing geriatric population coupled with the high prevalence of chronic diseases, the increasing technological innovations, and the growing demand for home-based lateral flow assay kits.

Infectious Disease Segment to Register Largest Share in the Rapid Diagnostics Market by 2029

The infectious disease segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is mainly attributed to the rising prevalence of infectious diseases and the growing demand for affordable infectious disease testing in emerging markets.

Hospitals & Clinics Segment to Dominate Global Rapid Diagnostics Market

The hospitals & clinics segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is mainly attributed to the increasing number of patient visits to hospitals for availing various healthcare services, such as diagnosis, treatments, and surgeries with well-equipped operating & diagnostic rooms, the presence of highly skilled healthcare professionals, the ease of accessibility, and better health coverage for hospital-based healthcare services from various private and group insurance plans.

Asia-Pacific: Fastest Growing Regional Market

North America is estimated to command the largest share of the global rapid diagnostics market in 2022, followed by Asia-Pacific, Europe, Latin America, and the Middle East & Africa. However, Asia-Pacific is expected to be the fastest-growing regional market due to the growing geriatric population, the rising prevalence of infectious & chronic diseases, and various government initiatives to promote health awareness.

Key Players

The report includes a competitive landscape based on an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past four years. The key players profiled in the global rapid diagnostics market report include Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), ACON Laboratories, Inc. (U.S.), Creative Diagnostics (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), BioMérieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).

Scope of the Report

Rapid Diagnostics Market, by Product

  • Kits
    • OTC Kits
    • Professional Kits
  • Equipment

Rapid Diagnostics Market, by Platform

  • Immunoassays
    • Lateral Flow Assays
    • Serological Assays
    • Other Immunoassays
  • Molecular Detection
  • Other Platforms
    (Note – Other Immunoassays includes flow through immunoassays and agglutination assays; and Other platforms mainly include coagulation tests, glucose monitoring systems, dipsticks, and other rapid diagnostic platforms)

Rapid Diagnostics Market, by Application

  • Infectious Diseases Testing
    • COVID-19 Testing
    • Healthcare-associated Infections (HAI) Testing
    • Hepatitis Testing
      • Hepatitis B
      • Hepatitis C
    • Tropical Diseases Testing
    • HIV Testing
    • Respiratory Diseases Testing (other than Influenza and COVID-19)
    • Influenza Testing
    • Sexually Transmitted Diseases (STD) Testing
    • Other Infectious Diseases Testing
  • Pregnancy & Fertility Testing
  • Cardiac Metabolism Testing
  • Cholesterol Testing
  • Tumor/Cancer Markers Testing
  • Blood Glucose Testing
  • Urinalysis
  • Hematology Testing
  • Other Tests
    (Note – Other tests include drugs of abuse, fecal occult, and coagulation tests; Other infectious disease testing include meningitis, norovirus (“stomach flu”), hand, foot and mouth disease (HFMD), and pertussis)

Rapid Diagnostics Market, by End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care/Self Testing
  • Other End Users

Global Rapid Diagnostics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Key questions answered in the report:

What is the Focus of the Global Rapid Diagnostics Market?

The global rapid diagnostics market covers the market sizes & forecasts for the various rapid diagnostic kits used for blood glucose testing, cardiac metabolism testing, infectious diseases testing, coagulation testing, pregnancy & fertility testing, fecal occult testing, hematology testing, tumor/cancer markers testing, drugs of abuse testing, urinalysis, and cholesterol testing. The rapid diagnostics market studied in this report involves the value analysis of various segments and subsegments of rapid diagnostic kits producers at the regional and country levels.

What is the Value of Revenue Generated from the Rapid Diagnostic Kits Globally? At What Rate is their Demand Expected to Grow for the Next 5–7 Years?

The global rapid diagnostics market is projected to reach $26.40 billion by 2029, at a CAGR of 1.4% during the forecast period.

Which Product Type is Estimated to Hold the Major Share of the Market?

Based on product, the kits segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is attributed to the rising adoption and repetitive kits usage. In addition, the growing portfolio of disease-specific kits for the early diagnosis of chronic diseases and the increasing technological advancements are other factors supporting the growth of this segment.

Which End User Segment of the Market is Projected to Create More Traction in the Rapid Diagnostics Market?

The hospitals & clinics segment is estimated to register the fastest CAGR during the forecast period due to the increasing number of patient visits to hospitals for availing various healthcare services, the presence of highly skilled healthcare professionals, the ease of accessibility, and better health coverage for hospital-based healthcare services from various private and group insurance plans.

What are the Key Factors Supporting the Growth of this Market? Also, What are the Major Opportunities for Existing Market Players and New Entrants in the Global Rapid Diagnostics Market?

The growing demand for POC diagnostics, emerging technological innovations, growing prevalence of infectious diseases, the rising prevalence of chronic diseases coupled with the increasing aging population, and the growing necessity for rapid decision making in emergency departments are the key factors driving the growth of the global rapid diagnostics market. Furthermore, the growing market potential in emerging economies, such as China and India, provides significant opportunities for existing market players and new entrants in this market.

Who are the Major Players Operating in the Global Rapid Diagnostics Market?

The key players operating in the global rapid diagnostics market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), ACON Laboratories, Inc. (U.S.), Creative Diagnostics (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), BioMérieux S.A. (France), Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).

Which Regions/Countries are Expected to Offer Significant Growth Opportunities for the Companies Operating in the Rapid Diagnostics Market?

Emerging economies from Asia, such as China and India, are projected to offer significant growth opportunities for the companies operating in this market. Additionally, the rising number of people suffering from non-communicable and infectious diseases, the growing population, and rising urbanization are the factors that are expected to offer significant growth opportunities in this region.

1.    Introduction 
       1.1.    Market Definition 
       1.2.    Market Ecosystem 
       1.3.    Currency 
       1.4.    Key Stakeholders 

2.    Research Methodology 
       2.1.    Research Process 
       2.2.    Data Collection & Validation 
                 2.2.1.    Secondary Research 
                 2.2.2.    Primary Research 
       2.3.    Market Assessment 
                 2.3.1.    Market Size Estimation 
                              2.3.1.1.    Bottom-up Approach 
                              2.3.1.2.    Top-down Approach 
                              2.3.1.3.    Growth Forecast 
                 2.3.2.    Market Share Analysis 
       2.4.    Assumptions for this Study 
       2.5.    Limitations for the Study 

3.    Executive Summary 

4.    Market Insights 
       4.1.    Market Overview 
       4.2.    Drivers 
                 4.2.1.    Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population 
                 4.2.2.    Growing Prevalence of Infectious Diseases 
                 4.2.3.    Increasing Need for Rapid Decision-Making 
                 4.2.4.    Growing Demand for Point-of-Care (POC) Diagnostics 
                 4.2.5.    Technological Innovations 
       4.3.    Restraints 
                 4.3.1.    Variance in Test Results 
       4.4.    Opportunities 
                 4.4.1.    Emerging Markets 
       4.5.    Challenges 
                 4.5.1.    Reluctance Toward Changing Existing Diagnostic Practices 
       4.6.    The Impact of COVID-19 on the Rapid Diagnostics Market 
       4.7.    Regulatory Affairs Analysis 
                 4.7.1.    U.S. 
                 4.7.2.    Europe 
                 4.7.3.    Asia-Pacific 
                 4.7.4.    Latin America 
                 4.7.5.    Middle East 
       4.8.    Rapid Diagnostics: Innovations & Upcoming Technologies 

5.    Global Rapid Diagnostics Market, by Product 
       5.1.    Introduction 
       5.2.    Kits 
                 5.2.1.    Professional Kits 
                 5.2.2.    OTC Kits 
       5.3.    Equipment 

6.    Global Rapid Diagnostics Market, by Platform 
       6.1.    Introduction 
       6.2.    Immunoassays 
                 6.2.1.    Lateral Flow Assays 
                 6.2.2.    Serological Tests 
                 6.2.3.    Other Immunoassays 
       6.3.    Molecular Detection Tests 
       6.4.    Other Rapid Diagnostic Platforms 

7.    Global Rapid Diagnostics Market, by Application 
       7.1.    Introduction 
       7.2.    Infectious Diseases Testing 
                 7.2.1.    COVID-19 Testing 
                 7.2.2.    Healthcare-associated Infections (HAI) Testing 
                 7.2.3.    Hepatitis Testing 
                              7.2.3.1.    Hepatitis B 
                              7.2.3.2.    Hepatitis C 
                 7.2.4.    Tropical Diseases Testing 
                 7.2.5.    HIV Testing 
                 7.2.6.    Respiratory Diseases Testing (other than Influenza and COVID-19) 
                 7.2.7.    Influenza Testing 
                 7.2.8.    Sexually Transmitted Diseases (STD) Testing 
                 7.2.9.    Other Infectious Diseases Testing 
       7.3.    Pregnancy & Fertility Testing 
       7.4.    Cardiac Metabolism Testing 
       7.5.    Cholesterol Testing 
       7.6.    Tumor/Cancer Markers Testing 
       7.7.    Blood Glucose Testing 
       7.8.    Urinalysis 
       7.9.    Hematology Testing 
       7.10.  Other Tests 

8.    Rapid Diagnostics Market, by End User 
       8.1.    Introduction 
       8.2.    Hospital & Clinics 
       8.3.    Diagnostic Laboratories 
       8.4.    Home Care/Self-testing 
       8.5.    Other End Users 

9.    Rapid Diagnostics Market, by Geography 
       9.1.    Introduction 
       9.2.    North America 
                 9.2.1.    U.S. 
                 9.2.2.    Canada 
       9.3.    Europe 
                 9.3.1.    Germany 
                 9.3.2.    U.K. 
                 9.3.3.    France 
                 9.3.4.    Italy 
                 9.3.5.    Spain 
                 9.3.6.    Rest of Europe (RoE) 
       9.4.    Asia-Pacific 
                 9.4.1.    China 
                 9.4.2.    Japan 
                 9.4.3.    India 
                 9.4.4.    Rest of Asia-Pacific (RoAPAC) 
       9.5.    Latin America 
       9.6.    Middle East & Africa 

10.    Competitive Landscape 
         10.1.    Introduction 
         10.2.    Key Growth Strategies 
         10.3.    Competitive Benchmarking 
         10.4.    Market Share Analysis (2021) 
                    10.4.1.    Abbott Laboratories (U.S.) 
                    10.4.2.    Becton, Dickinson and Company (U.S.) 
                    10.4.3.    F. Hoffmann-La Roche Ltd. (Switzerland) 

11.    Company Profiles (Business Overview, Financial Overview, Products Portfolio, Strategic Developments)
         11.1.    Abbott Laboratories  
         11.2.    Becton, Dickinson and Company (BD) 
         11.3.    Bio-Rad Laboratories, Inc. 
         11.4.    F. Hoffmann-La Roche Ltd 
         11.5.    ACON Laboratories, Inc. 
         11.6.    Creative Diagnostics 
         11.7.    Danaher Corporation 
         11.8.    Thermo Fisher Scientific Inc. 
         11.9.    BioMérieux S.A. 
         11.10.   Alfa Scientific Designs, Inc. 
         11.11.  BTNX Inc. 
         11.12.  Meridian Bioscience, Inc. 
         11.13.  Trinity Biotech plc 

12.    Appendix 
         12.1.    Questionnaire 
         12.2.    Available Customization 

List of Tables

Table 1    Rapid Diagnostics Market: Impact Analysis of Market Drivers (2022–2029) 
Table 2    Diabetes Prevalence in People Aged 65 Years and Above, by Region (2017 Vs. 2019 Vs. 2030) 
Table 3    Number of People Aged 65 Years and Above, by Region, 2019 Vs. 2050 (in Million) 
Table 4    Rapid Diagnostics Market: Impact Analysis of Market Restraints (2022–2029) 
Table 5    Percentage of Population Residing in Urban Areas (Emerging Countries) 
Table 6    Some of the Emergency Use Authorizations (EUAs) Granted for Rapid Diagnostics During the COVID-19 Pandemic 
Table 7    Global Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 8    Global Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 9    Global Rapid Diagnostic Kits Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 10    Global Professional Rapid Diagnostic Kits Market Size, by Country/Region, 2022–2029 (USD Million) 
Table 11    Prevalence of Diabetes, by Region, 2019–2045 (in Million) 
Table 12    Global OTC Rapid Diagnostic Kits Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 13    Key Companies Offering Test Readers/Analyzers 
Table 14    Global Rapid Diagnostics Equipment Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 15    Global Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 16    Global Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 17    Global Immunoassays Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 18    Recently Launched Lateral Flow Assays Kits for COVID-19 Testing 
Table 19    Key Companies Offering Lateral Flow Assays 
Table 20    Global Lateral Flow Assays Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 21    Key Companies Offering Serological Tests 
Table 22    Global Serological Tests Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 23    Global Other Immunoassays Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 24    Top Countries with the Highest Search Volume Index for Reverse Transcription-Polymerase Chain Reaction Tests (2020–2021) 
Table 25    Key Companies Offering Rapid Pcr Test Kits 
Table 26    Global Molecular Detection Tests Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 27    Global Other Rapid Diagnostic Platforms Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 28    Global Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 29    Global Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 30    Key Companies Offering Rapid Diagnostic Kits for Infectious Diseases Testing 
Table 31    Global Rapid Diagnostics Market Size for Infectious Diseases Testing, By Country/Region, 2020–2029 (USD Million) 
Table 32    Some of the Recently Launched and Approved Rapid Diagnostic Tests for COVID-19 Detection 
Table 33    Global Rapid Diagnostics Market Size for COVID-19 Testing, Country/Region, 2020–2029 (USD Million) 
Table 34    Global Rapid Diagnostics Market Size for Healthcare-Associated Infections (HAI) Testing, by Country/Region, 2020–2029 (USD Million) 
Table 35    Global Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 36    Global Rapid Diagnostics Market Size for Hepatitis Testing, by Country/Region, 2020–2029 (USD Million) 
Table 37    Global Rapid Diagnostics Market Size for Hepatitis B Testing, by Country/Region, 2020–2029 (USD Million) 
Table 38    Global Rapid Diagnostics Market Size for Hepatitis C Testing, by Country/Region, 2020–2029 (USD Million) 
Table 39    Incidence of Tropical Diseases (2019) 
Table 40    Global Rapid Diagnostics Market Size for Tropical Diseases Testing, By Country/Region, 2020–2029 (USD Million) 
Table 41    HIV Prevalence by Region (2020) 
Table 42    Global Rapid Diagnostics Market Size for HIV Testing, by Country/Region, 2020–2029 (USD Million) 
Table 43    Global Rapid Diagnostics Market Size for Respiratory Diseases Testing, By Country/Region, 2020–2029 (USD Million) 
Table 44    Global Rapid Diagnostics Market Size for Influenza Testing, by Country/Region, 2020–2029 (USD Million) 
Table 45    Global Rapid Diagnostics Market Size for Sexually Transmitted Diseases (STD) Testing, by Country/Region, 2020–2029 (USD Million) 
Table 46    Global Rapid Diagnostics Market Size for Other Infectious Diseases Testing, by Country/Region, 2020–2029 (USD Million) 
Table 47    Countries with High Fertility Rates 
Table 48    Key Companies Offering Rapid Diagnostic Kits for Pregnancy & Fertility Testing 
Table 49    Global Rapid Diagnostics Market Size for Pregnancy & Fertility Testing, by Country/Region, 2020–2029 (USD Million) 
Table 50    Key Companies Offering Rapid Diagnostic Kits for Cardiac Metabolism Testing 
Table 51    Global Rapid Diagnostics Market Size for Cardiac Metabolism Testing, by Country/Region, 2020–2029 (USD Million) 
Table 52    Global Rapid Diagnostics Market Size for Cholesterol Testing, by Country/Region, 2020–2029 (USD Million) 
Table 53    Key Companies Offering Tumor/Cancer Marker Testing Products 
Table 54    Global Rapid Diagnostics Market Size for Tumor/Cancer Markers Testing, By Country/Region, 2020–2029 (USD Million) 
Table 55    Number of People with Diabetes Aged 20–79 Years, by Region, 2019 Vs. 2030 Vs. 2045 (in Million) 
Table 56    Global Rapid Diagnostics Market Size for Blood Glucose Testing, By Country/Region, 2020–2029 (USD Million) 
Table 57    Global Rapid Diagnostics Market Size for Urinalysis, by Country/Region, 2020–2029 (USD Million) 
Table 58    Global Rapid Diagnostics Market Size for Hematology Testing, by Country/Region, 2020–2029 (USD Million) 
Table 59    Global Rapid Diagnostics Market Size for Other Tests, by Country/Region, 2020–2029 (USD Million) 
Table 60    Global Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 61    Global Rapid Diagnostics Market Size for Hospitals & Clinics, by Country/Region, 2020–2029 (USD Million) 
Table 62    Global Rapid Diagnostics Market Size for Diagnostic Laboratories, By Country/Region, 2020–2029 (USD Million) 
Table 63    Global Rapid Diagnostics Market Size for Home Care/Self-Testing, By Country/Region, 2020–2029 (USD Million) 
Table 64    Global Rapid Diagnostics Market Size for Other End Users, by Country/Region, 2020–2029 (USD Million) 
Table 65    Global Rapid Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 66    North America: Rapid Diagnostics Market Size, by Country, 2020–2029 (USD Million) 
Table 67    North America: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 68    North America: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 69    North America: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 70    North America: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 71    North America: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 72    North America: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million) 
Table 73    North America: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 74    North America: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 75    Rapid Diagnostic Kits Launched for Coronavirus Testing 
Table 76    U.S.: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 77    U.S.: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 78    U.S.: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 79    U.S.: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 80    U.S.: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 81    U.S.: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 82    U.S.: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 83    U.S.: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 84    Canada: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 85    Canada: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 86    Canada: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 87    Canada: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 88    Canada: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 89    Canada: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 90    Canada: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 91    Canada: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 92    Europe: Rapid Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 93    Europe: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 94    Europe: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 95    Europe: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 96    Europe: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 97    Europe: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 98    Europe: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 99    Europe: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 100    Europe: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 101    Recent Initiatives by the German Government to Tackle the Coronavirus Pandemic 
Table 102    Germany: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 103    Germany: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 104    Germany: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 105    Germany: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 106    Germany: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 107    Germany: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 108    Germany: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 109    Germany: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 110    U.K.: Number of Chlamydia Tests Conducted, 2018–2019 
Table 111    Recent Initiatives by the U.K. Government to Combat the COVID-19 Pandemic 
Table 112    U.K.: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 113    U.K.: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 114    U.K.: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 115    U.K.: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 116    U.K.: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 117    U.K.: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 118    U.K.: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 119    U.K.: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 120    France: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 121    France: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 122    France: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 123    France: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 124    France: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 125    France: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 126    France: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 127    France: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 128    Initiatives Undertaken by the Government of Italy to Tackle the COVID-19 Pandemic 
Table 129    Italy: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 130    Italy: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 131    Italy: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 132    Italy: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 133    Italy: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 134    Italy: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 135    Italy: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 136    Italy: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 137    Spain: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 138    Spain: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 139    Spain: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 140    Spain: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 141    Spain: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 142    Spain: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 143    Spain: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 144    Spain: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 145    Rest of Europe: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 146    Rest of Europe: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 147    Rest of Europe: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 148    Rest of Europe: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 149    Rest of Europe: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 150    Rest of Europe: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million) 
Table 151    Rest of Europe: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 152    Rest of Europe: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 153    Asia-Pacific: Rapid Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 154    Asia-Pacific: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 155    Asia-Pacific: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 156    Asia-Pacific: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 157    Asia-Pacific: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 158    Asia-Pacific: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 159    Asia-Pacific: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million) 
Table 160    Asia-Pacific: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 161    Asia-Pacific: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 162    China: Mass Testing Drives to Control the Spread of COVID-19 Infections 
Table 163    China: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 164    China: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 165    China: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 166    China: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 167    China: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 168    China: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 169    China: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 170    China: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 171    Japan: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 172    Japan: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 173    Japan: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 174    Japan: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 175    Japan: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 176    Japan: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 177    Japan: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 178    Japan: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 179    Recent Initiatives Launched by the Government of India to Combat the COVID-19 Pandemic 
Table 180    India: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 181    India: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 182    India: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 183    India: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 184    India: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 185    India: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 186    India: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 187    India: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 188    Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 189    Rest of Asia-Pacific: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 190    Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 191    Rest of Asia-Pacific: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 192    Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 193    Rest of Asia-Pacific: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 194    Rest of Asia-Pacific: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 195    Rest of Asia-Pacific: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 196    Latin America: Number of New HIV Cases, by Country (2019) 
Table 197    Latin America: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 198    Latin America: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 199    Latin America: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 200    Latin America: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 201    Latin America: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 202    Latin America: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million) 
Table 203    Latin America: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 204    Latin America: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 205    Middle East & Africa: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 206    Middle East & Africa: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 207    Middle East & Africa: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 208    Middle East & Africa: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 209    Middle East & Africa: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 210    Middle East & Africa: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 211    Middle East & Africa: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 212    Middle East & Africa: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 213    Recent Developments, by Company, 2018–2021 

List of Figures

Figure 1    Research Process 
Figure 2    Key Secondary Sources 
Figure 3    Primary Research Techniques 
Figure 4    Key Executives Interviewed 
Figure 5    Breakdown of Primary Interviews (Supply-side & Demand-side) 
Figure 6    Market Size Estimation 
Figure 7    Global Rapid Diagnostics Market Size, By Product, 2022 Vs. 2022 (USD Million) 
Figure 8    Global Rapid Diagnostics Market Size, By Platform, 2022 Vs. 2029 (USD Million) 
Figure 9    Global Rapid Diagnostics Market Size, By Application, 2029 Vs. 2022 (USD Million) 
Figure 10    Global Rapid Diagnostics Market Size, By End User, 2022 Vs. 2029 (USD Million) 
Figure 11    Global Rapid Diagnostics Market, By Geography 
Figure 12    Market Dynamics 
Figure 13    Global Percentage Share of The Population Aged 65 and Above (2010–2020) 
Figure 14    U.S.: Hepatitis A Virus (HAV) Infections (2013–2020) 
Figure 15    EU Regulatory Pathway - IVDR 2017/746 
Figure 16    Chinese Medical Device Classification and Pre-Market Requirements for Rapid Diagnostic Devices 
Figure 17    Global Rapid Diagnostics Market Size, By Product, 2022 Vs. 2029 (USD Million) 
Figure 18    Global Rapid Diagnostics Market Size, By Platform, 2022 Vs. 2029 (USD Million) 
Figure 19    Reverse Transcription-Polymerase Chain Reaction: Global Search Volume Index 
Figure 20    Global Rapid Diagnostics Market Size, By Application, 2022 Vs. 2029 (USD Million) 
Figure 21    U.S.: Estimated Acute Hepatitis C Cases, 2011–2020 
Figure 22    Estimated Number of New Cancer Cases, By Region, 2020–2040 (in Million) 
Figure 23    Total Number of Accredited Testing Laboratories (Iso/Iec 17025), 2016–2020 
Figure 24    Prevalence of Diabetes Across The World (in Million) 
Figure 25    Global Rapid Diagnostics Market Size, By End User, 2022–2029 (USD Million) 
Figure 26    U.S.: Home Healthcare Spending, 2015–2026 (USD Million) 
Figure 27    Global Rapid Diagnostics Market Size, By Region, 2022 Vs. 2029 (USD Million) 
Figure 28    North America: Rapid Diagnostics Market Snapshot 
Figure 29    U.S.: Number of HIV-Positive Patients, 2017–2020 
Figure 30    Canada: Number of People Aged 65 Years and Above, 2016–2020 
Figure 31    Canada: Number of Inpatient Admissions in Acute-Care Hospitals, 2016–2020 (Per 1,00,000 Population) 
Figure 32    Europe: Rapid Diagnostics Market Snapshot 
Figure 33    U.K: Estimated Number of Cancer Cases, 2010–2030 (in Million) 
Figure 34   U.K.: Number of Diabetes and Urogenital, Blood, and Endocrine Disease Cases - DALYS (Disability-Adjusted Life Years), 2017 2020 (in Thousand) 
Figure 35    U.K.: Number of People Diagnosed With Sexually Transmitted Infections, 2018–2020 (in Thousand) 
Figure 36    France: Percentage of Population Aged 65 Years and Above, 2016–2020 
Figure 37    France: Prevalence of Chronic Diseases in People Aged 65 and Above (2019) 
Figure 38    Italy: Prevalence of Healthcare-Associated Infections in Acute-Care Wards, 2016–2019 
Figure 39    Italy: Ovarian Cancer Cases Diagnosed, 2018–2020 
Figure 40    Italy: Total Number of New Diagnostic Laboratories for BRCA1/2 Testing, 2010–2019 
Figure 41    Number of Hiv Tests Performed in Catalonia (Spain), 2014–2020 
Figure 42    Asia-Pacific: Rapid Diagnostics Market Snapshot 
Figure 43    China: Independent Medical Laboratories Market, 2015–2019 (USD Million) 
Figure 44    Japan: Percentage Growth in The Aging Population (2015–2021) 
Figure 45    Key Growth Strategies Adopted By Leading Players (2018–2021) 
Figure 46    Rapid Diagnostics Market: Competitive Benchmarking 
Figure 47    Market Share Analysis: Rapid Diagnostics Industry (2021) 
Figure 48    Abbott Laboratories: Financial Overview (2021) 
Figure 49    Becton, Dickinson and Company: Financial Overview (2021) 
Figure 50    Bio-Rad Laboratories, Inc.: Financial Overview (2021) 
Figure 51    F. Hoffmann-La Roche Ltd: Financial Overview (2021) 
Figure 52    Danaher Corporation: Financial Overview (2021) 
Figure 53    Thermo Fisher Scientific Inc.: Financial Overview (2021) 
Figure 54    BioMérieux S.A.: Financial Overview (2020) 
Figure 55    Meridian Bioscience, Inc.: Financial Overview (2021) 
Figure 56    Trinity Biotech plc: Financial Overview (2020) 

 
Name can only consist of alphabets.
Please provide your full name.
 
Please provide valid email address.
Please provide your email address.
 
Please provide your job title.
 
Please provide your company name.
 
Please provide your company name.
 
Please provide valid phone number.
Please provide your phone number.
 
Please enter minimum 10 characters.
 
Please enter Captcha.
Please enter valid Captcha.

This website is secure and we do not share your personal information with any third party. Privacy Policy

Related Research

The Rapid Diagnostics Market is expected to grow at a CAGR of 1.4% from 2022–2029 to reach $26.4 billion by 2029. A rapid diagnostic test (RDT) is a medical diagnostic test that provides diagnostic results efficiently and immediately (within 1 hour) while the patient is still at the health facility, screening site, or other health care provider.

RDT kits are widely used in hospitals and clinical laboratories for the qualitative and quantitative detection of specific antigens, antibodies, and genetic material or proteins associated with a specific health condition or disease, helping to uncover the underlying mechanisms of disease and enabling doctors and healthcare workers to make crucial medical decisions.

The growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, and emerging technological innovations are the key factors driving the growth of the global rapid diagnostics market.

Rapid Diagnostics Market

Click here to: Get Sample Pages of this Report  

Impact of COVID-19 on the Rapid Diagnostics Market

The COVID-19 pandemic positively impacted that rapid diagnostics market in terms of revenue; however, the pandemic negatively impacted the sales of routine testing kits used mainly to screen cancer, blood glucose, cardiac markers, lipid profile, cholesterol, and other infectious diseases.

The COVID-19 pandemic led to a reduction in the number of overall diagnostic testing conducted globally due to the lockdowns and restrictions imposed by several governments worldwide, which translated further into reduced instrument installations and reduced sales of reagents and consumables; however, the loss of sales occurred in routine testing kits was compensated by high sales of COVID-19-related tests.

Governments worldwide depended on rapid diagnostic kits to screen COVID-19 infections within the population. Also, various governments took numerous initiatives to support the testing needs of their respective countries. Some of them are listed below:

  • In April 2021, the federal government of Germany made it mandatory for employers in Germany to offer free COVID-19 self-testing kits once a week to employees not working from home.
  • In April 2021, the U.K. Government announced its plans to design a system of COVID-19 passports that will allow people to people to attend public events, including sports games, by either showing proof of vaccination or a recent negative test. The Government also announced its plans to provide free test kits through local pharmacy stores, community centers, and home delivery services.
  • In March 2021, The German Federal Ministry of Health approved the sale of COVID-19 rapid antigen tests in supermarket chains, drug stores, pharmacies, and e-commerce websites. For this purpose, Germany's Federal Institute for Drugs and Medical Devices (BfArM) provided special approval to seven COVID-19 rapid antigen test kits for home use.
  • In March 2021, Becker's Healthcare published that the U.S. government is set to launch a national testing strategy to control the spread of COVID-19. Through this testing strategy, the Government will open four COVID-19 testing hubs across the country with an investment of $650 million. These testing hubs were aimed at increasing the number of monthly national testing by 25 million.
  • In October 2020, the Italian Health Ministry announced its plans to conduct rapid COVID-19 diagnostics tests throughout the country to control the rising prevalence of COVID-19 infections.

Despite the supply and logistics challenges due to the COVID-19 pandemic, numerous rapid diagnostics products were launched to fulfill the demand for COVID-19 infection diagnosis in both symptomatic and asymptomatic people. In addition, to align themselves with the travel restrictions, companies operating in the market started to hold web meetings and webinars to interact with their customer and shareholders and provide product descriptions, customer demonstrations, and applications training.

Furthermore, countries worldwide have started to relax lockdown restrictions due to the lower number of new infections and the growing number of people with COVID-19 vaccinations, which is expected to propel the number of routine tests globally. Thus, the COVID-19 pandemic negatively impacted the sale of routine testing kits globally; however, high sales of COVID-19-related tests compensated for the loss of sales in routine testing kits.

Key Findings in the Global Rapid Diagnostics Market Study:

Kits segment Generated Larger Proportion of Revenue Compared to Test Readers/Analysers

The kits segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment can be attributed to the rising adoption and repetitive kits usage. In addition, the growing portfolio of disease-specific kits for the early diagnosis of chronic diseases and the increasing technological advancements are other factors supporting the growth of this segment.

Immunoassays to Dominate the Market

The immunoassays segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is mainly attributed to the increasing geriatric population coupled with the high prevalence of chronic diseases, the increasing technological innovations, and the growing demand for home-based lateral flow assay kits.

Infectious Disease Segment to Register Largest Share in the Rapid Diagnostics Market by 2029

The infectious disease segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is mainly attributed to the rising prevalence of infectious diseases and the growing demand for affordable infectious disease testing in emerging markets.

Hospitals & Clinics Segment to Dominate Global Rapid Diagnostics Market

The hospitals & clinics segment is estimated to account for the largest share of the rapid diagnostics market in 2022. The large share of this segment is mainly attributed to the increasing number of patient visits to hospitals for availing various healthcare services, such as diagnosis, treatments, and surgeries with well-equipped operating & diagnostic rooms, the presence of highly skilled healthcare professionals, the ease of accessibility, and better health coverage for hospital-based healthcare services from various private and group insurance plans.

Asia-Pacific: Fastest Growing Regional Market

North America is estimated to command the largest share of the global rapid diagnostics market in 2022, followed by Asia-Pacific, Europe, Latin America, and the Middle East & Africa. However, Asia-Pacific is expected to be the fastest-growing regional market due to the growing geriatric population, the rising prevalence of infectious & chronic diseases, and various government initiatives to promote health awareness.

Key Players

The report includes a competitive landscape based on an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past four years. The key players profiled in the global rapid diagnostics market report include Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), ACON Laboratories, Inc. (U.S.), Creative Diagnostics (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), BioMérieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).

Scope of the Report

Rapid Diagnostics Market, by Product

  • Kits
    • OTC Kits
    • Professional Kits
  • Equipment

Rapid Diagnostics Market, by Platform

  • Immunoassays
    • Lateral Flow Assays
    • Serological Assays
    • Other Immunoassays
  • Molecular Detection
  • Other Platforms
    (Note – Other Immunoassays includes flow through immunoassays and agglutination assays; and Other platforms mainly include coagulation tests, glucose monitoring systems, dipsticks, and other rapid diagnostic platforms)

Rapid Diagnostics Market, by Application

  • Infectious Diseases Testing
    • COVID-19 Testing
    • Healthcare-associated Infections (HAI) Testing
    • Hepatitis Testing
      • Hepatitis B
      • Hepatitis C
    • Tropical Diseases Testing
    • HIV Testing
    • Respiratory Diseases Testing (other than Influenza and COVID-19)
    • Influenza Testing
    • Sexually Transmitted Diseases (STD) Testing
    • Other Infectious Diseases Testing
  • Pregnancy & Fertility Testing
  • Cardiac Metabolism Testing
  • Cholesterol Testing
  • Tumor/Cancer Markers Testing
  • Blood Glucose Testing
  • Urinalysis
  • Hematology Testing
  • Other Tests
    (Note – Other tests include drugs of abuse, fecal occult, and coagulation tests; Other infectious disease testing include meningitis, norovirus (“stomach flu”), hand, foot and mouth disease (HFMD), and pertussis)

Rapid Diagnostics Market, by End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care/Self Testing
  • Other End Users

Global Rapid Diagnostics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Key questions answered in the report:

  Request Sample

1.    Introduction 
       1.1.    Market Definition 
       1.2.    Market Ecosystem 
       1.3.    Currency 
       1.4.    Key Stakeholders 

2.    Research Methodology 
       2.1.    Research Process 
       2.2.    Data Collection & Validation 
                 2.2.1.    Secondary Research 
                 2.2.2.    Primary Research 
       2.3.    Market Assessment 
                 2.3.1.    Market Size Estimation 
                              2.3.1.1.    Bottom-up Approach 
                              2.3.1.2.    Top-down Approach 
                              2.3.1.3.    Growth Forecast 
                 2.3.2.    Market Share Analysis 
       2.4.    Assumptions for this Study 
       2.5.    Limitations for the Study 

3.    Executive Summary 

4.    Market Insights 
       4.1.    Market Overview 
       4.2.    Drivers 
                 4.2.1.    Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population 
                 4.2.2.    Growing Prevalence of Infectious Diseases 
                 4.2.3.    Increasing Need for Rapid Decision-Making 
                 4.2.4.    Growing Demand for Point-of-Care (POC) Diagnostics 
                 4.2.5.    Technological Innovations 
       4.3.    Restraints 
                 4.3.1.    Variance in Test Results 
       4.4.    Opportunities 
                 4.4.1.    Emerging Markets 
       4.5.    Challenges 
                 4.5.1.    Reluctance Toward Changing Existing Diagnostic Practices 
       4.6.    The Impact of COVID-19 on the Rapid Diagnostics Market 
       4.7.    Regulatory Affairs Analysis 
                 4.7.1.    U.S. 
                 4.7.2.    Europe 
                 4.7.3.    Asia-Pacific 
                 4.7.4.    Latin America 
                 4.7.5.    Middle East 
       4.8.    Rapid Diagnostics: Innovations & Upcoming Technologies 

5.    Global Rapid Diagnostics Market, by Product 
       5.1.    Introduction 
       5.2.    Kits 
                 5.2.1.    Professional Kits 
                 5.2.2.    OTC Kits 
       5.3.    Equipment 

6.    Global Rapid Diagnostics Market, by Platform 
       6.1.    Introduction 
       6.2.    Immunoassays 
                 6.2.1.    Lateral Flow Assays 
                 6.2.2.    Serological Tests 
                 6.2.3.    Other Immunoassays 
       6.3.    Molecular Detection Tests 
       6.4.    Other Rapid Diagnostic Platforms 

7.    Global Rapid Diagnostics Market, by Application 
       7.1.    Introduction 
       7.2.    Infectious Diseases Testing 
                 7.2.1.    COVID-19 Testing 
                 7.2.2.    Healthcare-associated Infections (HAI) Testing 
                 7.2.3.    Hepatitis Testing 
                              7.2.3.1.    Hepatitis B 
                              7.2.3.2.    Hepatitis C 
                 7.2.4.    Tropical Diseases Testing 
                 7.2.5.    HIV Testing 
                 7.2.6.    Respiratory Diseases Testing (other than Influenza and COVID-19) 
                 7.2.7.    Influenza Testing 
                 7.2.8.    Sexually Transmitted Diseases (STD) Testing 
                 7.2.9.    Other Infectious Diseases Testing 
       7.3.    Pregnancy & Fertility Testing 
       7.4.    Cardiac Metabolism Testing 
       7.5.    Cholesterol Testing 
       7.6.    Tumor/Cancer Markers Testing 
       7.7.    Blood Glucose Testing 
       7.8.    Urinalysis 
       7.9.    Hematology Testing 
       7.10.  Other Tests 

8.    Rapid Diagnostics Market, by End User 
       8.1.    Introduction 
       8.2.    Hospital & Clinics 
       8.3.    Diagnostic Laboratories 
       8.4.    Home Care/Self-testing 
       8.5.    Other End Users 

9.    Rapid Diagnostics Market, by Geography 
       9.1.    Introduction 
       9.2.    North America 
                 9.2.1.    U.S. 
                 9.2.2.    Canada 
       9.3.    Europe 
                 9.3.1.    Germany 
                 9.3.2.    U.K. 
                 9.3.3.    France 
                 9.3.4.    Italy 
                 9.3.5.    Spain 
                 9.3.6.    Rest of Europe (RoE) 
       9.4.    Asia-Pacific 
                 9.4.1.    China 
                 9.4.2.    Japan 
                 9.4.3.    India 
                 9.4.4.    Rest of Asia-Pacific (RoAPAC) 
       9.5.    Latin America 
       9.6.    Middle East & Africa 

10.    Competitive Landscape 
         10.1.    Introduction 
         10.2.    Key Growth Strategies 
         10.3.    Competitive Benchmarking 
         10.4.    Market Share Analysis (2021) 
                    10.4.1.    Abbott Laboratories (U.S.) 
                    10.4.2.    Becton, Dickinson and Company (U.S.) 
                    10.4.3.    F. Hoffmann-La Roche Ltd. (Switzerland) 

11.    Company Profiles (Business Overview, Financial Overview, Products Portfolio, Strategic Developments)
         11.1.    Abbott Laboratories  
         11.2.    Becton, Dickinson and Company (BD) 
         11.3.    Bio-Rad Laboratories, Inc. 
         11.4.    F. Hoffmann-La Roche Ltd 
         11.5.    ACON Laboratories, Inc. 
         11.6.    Creative Diagnostics 
         11.7.    Danaher Corporation 
         11.8.    Thermo Fisher Scientific Inc. 
         11.9.    BioMérieux S.A. 
         11.10.   Alfa Scientific Designs, Inc. 
         11.11.  BTNX Inc. 
         11.12.  Meridian Bioscience, Inc. 
         11.13.  Trinity Biotech plc 

12.    Appendix 
         12.1.    Questionnaire 
         12.2.    Available Customization 

List of Tables

Table 1    Rapid Diagnostics Market: Impact Analysis of Market Drivers (2022–2029) 
Table 2    Diabetes Prevalence in People Aged 65 Years and Above, by Region (2017 Vs. 2019 Vs. 2030) 
Table 3    Number of People Aged 65 Years and Above, by Region, 2019 Vs. 2050 (in Million) 
Table 4    Rapid Diagnostics Market: Impact Analysis of Market Restraints (2022–2029) 
Table 5    Percentage of Population Residing in Urban Areas (Emerging Countries) 
Table 6    Some of the Emergency Use Authorizations (EUAs) Granted for Rapid Diagnostics During the COVID-19 Pandemic 
Table 7    Global Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 8    Global Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 9    Global Rapid Diagnostic Kits Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 10    Global Professional Rapid Diagnostic Kits Market Size, by Country/Region, 2022–2029 (USD Million) 
Table 11    Prevalence of Diabetes, by Region, 2019–2045 (in Million) 
Table 12    Global OTC Rapid Diagnostic Kits Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 13    Key Companies Offering Test Readers/Analyzers 
Table 14    Global Rapid Diagnostics Equipment Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 15    Global Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 16    Global Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 17    Global Immunoassays Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 18    Recently Launched Lateral Flow Assays Kits for COVID-19 Testing 
Table 19    Key Companies Offering Lateral Flow Assays 
Table 20    Global Lateral Flow Assays Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 21    Key Companies Offering Serological Tests 
Table 22    Global Serological Tests Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 23    Global Other Immunoassays Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 24    Top Countries with the Highest Search Volume Index for Reverse Transcription-Polymerase Chain Reaction Tests (2020–2021) 
Table 25    Key Companies Offering Rapid Pcr Test Kits 
Table 26    Global Molecular Detection Tests Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 27    Global Other Rapid Diagnostic Platforms Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 28    Global Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 29    Global Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 30    Key Companies Offering Rapid Diagnostic Kits for Infectious Diseases Testing 
Table 31    Global Rapid Diagnostics Market Size for Infectious Diseases Testing, By Country/Region, 2020–2029 (USD Million) 
Table 32    Some of the Recently Launched and Approved Rapid Diagnostic Tests for COVID-19 Detection 
Table 33    Global Rapid Diagnostics Market Size for COVID-19 Testing, Country/Region, 2020–2029 (USD Million) 
Table 34    Global Rapid Diagnostics Market Size for Healthcare-Associated Infections (HAI) Testing, by Country/Region, 2020–2029 (USD Million) 
Table 35    Global Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 36    Global Rapid Diagnostics Market Size for Hepatitis Testing, by Country/Region, 2020–2029 (USD Million) 
Table 37    Global Rapid Diagnostics Market Size for Hepatitis B Testing, by Country/Region, 2020–2029 (USD Million) 
Table 38    Global Rapid Diagnostics Market Size for Hepatitis C Testing, by Country/Region, 2020–2029 (USD Million) 
Table 39    Incidence of Tropical Diseases (2019) 
Table 40    Global Rapid Diagnostics Market Size for Tropical Diseases Testing, By Country/Region, 2020–2029 (USD Million) 
Table 41    HIV Prevalence by Region (2020) 
Table 42    Global Rapid Diagnostics Market Size for HIV Testing, by Country/Region, 2020–2029 (USD Million) 
Table 43    Global Rapid Diagnostics Market Size for Respiratory Diseases Testing, By Country/Region, 2020–2029 (USD Million) 
Table 44    Global Rapid Diagnostics Market Size for Influenza Testing, by Country/Region, 2020–2029 (USD Million) 
Table 45    Global Rapid Diagnostics Market Size for Sexually Transmitted Diseases (STD) Testing, by Country/Region, 2020–2029 (USD Million) 
Table 46    Global Rapid Diagnostics Market Size for Other Infectious Diseases Testing, by Country/Region, 2020–2029 (USD Million) 
Table 47    Countries with High Fertility Rates 
Table 48    Key Companies Offering Rapid Diagnostic Kits for Pregnancy & Fertility Testing 
Table 49    Global Rapid Diagnostics Market Size for Pregnancy & Fertility Testing, by Country/Region, 2020–2029 (USD Million) 
Table 50    Key Companies Offering Rapid Diagnostic Kits for Cardiac Metabolism Testing 
Table 51    Global Rapid Diagnostics Market Size for Cardiac Metabolism Testing, by Country/Region, 2020–2029 (USD Million) 
Table 52    Global Rapid Diagnostics Market Size for Cholesterol Testing, by Country/Region, 2020–2029 (USD Million) 
Table 53    Key Companies Offering Tumor/Cancer Marker Testing Products 
Table 54    Global Rapid Diagnostics Market Size for Tumor/Cancer Markers Testing, By Country/Region, 2020–2029 (USD Million) 
Table 55    Number of People with Diabetes Aged 20–79 Years, by Region, 2019 Vs. 2030 Vs. 2045 (in Million) 
Table 56    Global Rapid Diagnostics Market Size for Blood Glucose Testing, By Country/Region, 2020–2029 (USD Million) 
Table 57    Global Rapid Diagnostics Market Size for Urinalysis, by Country/Region, 2020–2029 (USD Million) 
Table 58    Global Rapid Diagnostics Market Size for Hematology Testing, by Country/Region, 2020–2029 (USD Million) 
Table 59    Global Rapid Diagnostics Market Size for Other Tests, by Country/Region, 2020–2029 (USD Million) 
Table 60    Global Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 61    Global Rapid Diagnostics Market Size for Hospitals & Clinics, by Country/Region, 2020–2029 (USD Million) 
Table 62    Global Rapid Diagnostics Market Size for Diagnostic Laboratories, By Country/Region, 2020–2029 (USD Million) 
Table 63    Global Rapid Diagnostics Market Size for Home Care/Self-Testing, By Country/Region, 2020–2029 (USD Million) 
Table 64    Global Rapid Diagnostics Market Size for Other End Users, by Country/Region, 2020–2029 (USD Million) 
Table 65    Global Rapid Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 66    North America: Rapid Diagnostics Market Size, by Country, 2020–2029 (USD Million) 
Table 67    North America: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 68    North America: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 69    North America: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 70    North America: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 71    North America: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 72    North America: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million) 
Table 73    North America: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 74    North America: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 75    Rapid Diagnostic Kits Launched for Coronavirus Testing 
Table 76    U.S.: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 77    U.S.: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 78    U.S.: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 79    U.S.: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 80    U.S.: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 81    U.S.: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 82    U.S.: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 83    U.S.: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 84    Canada: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 85    Canada: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 86    Canada: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 87    Canada: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 88    Canada: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 89    Canada: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 90    Canada: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 91    Canada: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 92    Europe: Rapid Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 93    Europe: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 94    Europe: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 95    Europe: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 96    Europe: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 97    Europe: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 98    Europe: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 99    Europe: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 100    Europe: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 101    Recent Initiatives by the German Government to Tackle the Coronavirus Pandemic 
Table 102    Germany: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 103    Germany: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 104    Germany: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 105    Germany: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 106    Germany: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 107    Germany: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 108    Germany: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 109    Germany: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 110    U.K.: Number of Chlamydia Tests Conducted, 2018–2019 
Table 111    Recent Initiatives by the U.K. Government to Combat the COVID-19 Pandemic 
Table 112    U.K.: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 113    U.K.: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 114    U.K.: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 115    U.K.: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 116    U.K.: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 117    U.K.: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 118    U.K.: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 119    U.K.: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 120    France: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 121    France: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 122    France: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 123    France: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 124    France: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 125    France: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 126    France: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 127    France: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 128    Initiatives Undertaken by the Government of Italy to Tackle the COVID-19 Pandemic 
Table 129    Italy: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 130    Italy: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 131    Italy: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 132    Italy: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 133    Italy: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 134    Italy: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 135    Italy: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 136    Italy: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 137    Spain: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 138    Spain: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 139    Spain: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 140    Spain: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 141    Spain: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 142    Spain: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 143    Spain: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 144    Spain: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 145    Rest of Europe: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 146    Rest of Europe: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 147    Rest of Europe: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 148    Rest of Europe: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 149    Rest of Europe: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 150    Rest of Europe: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million) 
Table 151    Rest of Europe: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 152    Rest of Europe: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 153    Asia-Pacific: Rapid Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 154    Asia-Pacific: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 155    Asia-Pacific: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 156    Asia-Pacific: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 157    Asia-Pacific: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 158    Asia-Pacific: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 159    Asia-Pacific: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million) 
Table 160    Asia-Pacific: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 161    Asia-Pacific: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 162    China: Mass Testing Drives to Control the Spread of COVID-19 Infections 
Table 163    China: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 164    China: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 165    China: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 166    China: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 167    China: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 168    China: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 169    China: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 170    China: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 171    Japan: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 172    Japan: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 173    Japan: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 174    Japan: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 175    Japan: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 176    Japan: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 177    Japan: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 178    Japan: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 179    Recent Initiatives Launched by the Government of India to Combat the COVID-19 Pandemic 
Table 180    India: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 181    India: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 182    India: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 183    India: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 184    India: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 185    India: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 186    India: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 187    India: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 188    Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 189    Rest of Asia-Pacific: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 190    Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 191    Rest of Asia-Pacific: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 192    Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 193    Rest of Asia-Pacific: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 194    Rest of Asia-Pacific: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 195    Rest of Asia-Pacific: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 196    Latin America: Number of New HIV Cases, by Country (2019) 
Table 197    Latin America: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 198    Latin America: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 199    Latin America: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 200    Latin America: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 201    Latin America: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 202    Latin America: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million) 
Table 203    Latin America: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 204    Latin America: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 205    Middle East & Africa: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 206    Middle East & Africa: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 207    Middle East & Africa: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 208    Middle East & Africa: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 209    Middle East & Africa: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 210    Middle East & Africa: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 211    Middle East & Africa: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 212    Middle East & Africa: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 213    Recent Developments, by Company, 2018–2021 

List of Figures

Figure 1    Research Process 
Figure 2    Key Secondary Sources 
Figure 3    Primary Research Techniques 
Figure 4    Key Executives Interviewed 
Figure 5    Breakdown of Primary Interviews (Supply-side & Demand-side) 
Figure 6    Market Size Estimation 
Figure 7    Global Rapid Diagnostics Market Size, By Product, 2022 Vs. 2022 (USD Million) 
Figure 8    Global Rapid Diagnostics Market Size, By Platform, 2022 Vs. 2029 (USD Million) 
Figure 9    Global Rapid Diagnostics Market Size, By Application, 2029 Vs. 2022 (USD Million) 
Figure 10    Global Rapid Diagnostics Market Size, By End User, 2022 Vs. 2029 (USD Million) 
Figure 11    Global Rapid Diagnostics Market, By Geography 
Figure 12    Market Dynamics 
Figure 13    Global Percentage Share of The Population Aged 65 and Above (2010–2020) 
Figure 14    U.S.: Hepatitis A Virus (HAV) Infections (2013–2020) 
Figure 15    EU Regulatory Pathway - IVDR 2017/746 
Figure 16    Chinese Medical Device Classification and Pre-Market Requirements for Rapid Diagnostic Devices 
Figure 17    Global Rapid Diagnostics Market Size, By Product, 2022 Vs. 2029 (USD Million) 
Figure 18    Global Rapid Diagnostics Market Size, By Platform, 2022 Vs. 2029 (USD Million) 
Figure 19    Reverse Transcription-Polymerase Chain Reaction: Global Search Volume Index 
Figure 20    Global Rapid Diagnostics Market Size, By Application, 2022 Vs. 2029 (USD Million) 
Figure 21    U.S.: Estimated Acute Hepatitis C Cases, 2011–2020 
Figure 22    Estimated Number of New Cancer Cases, By Region, 2020–2040 (in Million) 
Figure 23    Total Number of Accredited Testing Laboratories (Iso/Iec 17025), 2016–2020 
Figure 24    Prevalence of Diabetes Across The World (in Million) 
Figure 25    Global Rapid Diagnostics Market Size, By End User, 2022–2029 (USD Million) 
Figure 26    U.S.: Home Healthcare Spending, 2015–2026 (USD Million) 
Figure 27    Global Rapid Diagnostics Market Size, By Region, 2022 Vs. 2029 (USD Million) 
Figure 28    North America: Rapid Diagnostics Market Snapshot 
Figure 29    U.S.: Number of HIV-Positive Patients, 2017–2020 
Figure 30    Canada: Number of People Aged 65 Years and Above, 2016–2020 
Figure 31    Canada: Number of Inpatient Admissions in Acute-Care Hospitals, 2016–2020 (Per 1,00,000 Population) 
Figure 32    Europe: Rapid Diagnostics Market Snapshot 
Figure 33    U.K: Estimated Number of Cancer Cases, 2010–2030 (in Million) 
Figure 34   U.K.: Number of Diabetes and Urogenital, Blood, and Endocrine Disease Cases - DALYS (Disability-Adjusted Life Years), 2017 2020 (in Thousand) 
Figure 35    U.K.: Number of People Diagnosed With Sexually Transmitted Infections, 2018–2020 (in Thousand) 
Figure 36    France: Percentage of Population Aged 65 Years and Above, 2016–2020 
Figure 37    France: Prevalence of Chronic Diseases in People Aged 65 and Above (2019) 
Figure 38    Italy: Prevalence of Healthcare-Associated Infections in Acute-Care Wards, 2016–2019 
Figure 39    Italy: Ovarian Cancer Cases Diagnosed, 2018–2020 
Figure 40    Italy: Total Number of New Diagnostic Laboratories for BRCA1/2 Testing, 2010–2019 
Figure 41    Number of Hiv Tests Performed in Catalonia (Spain), 2014–2020 
Figure 42    Asia-Pacific: Rapid Diagnostics Market Snapshot 
Figure 43    China: Independent Medical Laboratories Market, 2015–2019 (USD Million) 
Figure 44    Japan: Percentage Growth in The Aging Population (2015–2021) 
Figure 45    Key Growth Strategies Adopted By Leading Players (2018–2021) 
Figure 46    Rapid Diagnostics Market: Competitive Benchmarking 
Figure 47    Market Share Analysis: Rapid Diagnostics Industry (2021) 
Figure 48    Abbott Laboratories: Financial Overview (2021) 
Figure 49    Becton, Dickinson and Company: Financial Overview (2021) 
Figure 50    Bio-Rad Laboratories, Inc.: Financial Overview (2021) 
Figure 51    F. Hoffmann-La Roche Ltd: Financial Overview (2021) 
Figure 52    Danaher Corporation: Financial Overview (2021) 
Figure 53    Thermo Fisher Scientific Inc.: Financial Overview (2021) 
Figure 54    BioMérieux S.A.: Financial Overview (2020) 
Figure 55    Meridian Bioscience, Inc.: Financial Overview (2021) 
Figure 56    Trinity Biotech plc: Financial Overview (2020) 

  Request Sample

1.    Introduction 
       1.1.    Market Definition 
       1.2.    Market Ecosystem 
       1.3.    Currency 
       1.4.    Key Stakeholders 

2.    Research Methodology 
       2.1.    Research Process 
       2.2.    Data Collection & Validation 
                 2.2.1.    Secondary Research 
                 2.2.2.    Primary Research 
       2.3.    Market Assessment 
                 2.3.1.    Market Size Estimation 
                              2.3.1.1.    Bottom-up Approach 
                              2.3.1.2.    Top-down Approach 
                              2.3.1.3.    Growth Forecast 
                 2.3.2.    Market Share Analysis 
       2.4.    Assumptions for this Study 
       2.5.    Limitations for the Study 

3.    Executive Summary 

4.    Market Insights 
       4.1.    Market Overview 
       4.2.    Drivers 
                 4.2.1.    Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population 
                 4.2.2.    Growing Prevalence of Infectious Diseases 
                 4.2.3.    Increasing Need for Rapid Decision-Making 
                 4.2.4.    Growing Demand for Point-of-Care (POC) Diagnostics 
                 4.2.5.    Technological Innovations 
       4.3.    Restraints 
                 4.3.1.    Variance in Test Results 
       4.4.    Opportunities 
                 4.4.1.    Emerging Markets 
       4.5.    Challenges 
                 4.5.1.    Reluctance Toward Changing Existing Diagnostic Practices 
       4.6.    The Impact of COVID-19 on the Rapid Diagnostics Market 
       4.7.    Regulatory Affairs Analysis 
                 4.7.1.    U.S. 
                 4.7.2.    Europe 
                 4.7.3.    Asia-Pacific 
                 4.7.4.    Latin America 
                 4.7.5.    Middle East 
       4.8.    Rapid Diagnostics: Innovations & Upcoming Technologies 

5.    Global Rapid Diagnostics Market, by Product 
       5.1.    Introduction 
       5.2.    Kits 
                 5.2.1.    Professional Kits 
                 5.2.2.    OTC Kits 
       5.3.    Equipment 

6.    Global Rapid Diagnostics Market, by Platform 
       6.1.    Introduction 
       6.2.    Immunoassays 
                 6.2.1.    Lateral Flow Assays 
                 6.2.2.    Serological Tests 
                 6.2.3.    Other Immunoassays 
       6.3.    Molecular Detection Tests 
       6.4.    Other Rapid Diagnostic Platforms 

7.    Global Rapid Diagnostics Market, by Application 
       7.1.    Introduction 
       7.2.    Infectious Diseases Testing 
                 7.2.1.    COVID-19 Testing 
                 7.2.2.    Healthcare-associated Infections (HAI) Testing 
                 7.2.3.    Hepatitis Testing 
                              7.2.3.1.    Hepatitis B 
                              7.2.3.2.    Hepatitis C 
                 7.2.4.    Tropical Diseases Testing 
                 7.2.5.    HIV Testing 
                 7.2.6.    Respiratory Diseases Testing (other than Influenza and COVID-19) 
                 7.2.7.    Influenza Testing 
                 7.2.8.    Sexually Transmitted Diseases (STD) Testing 
                 7.2.9.    Other Infectious Diseases Testing 
       7.3.    Pregnancy & Fertility Testing 
       7.4.    Cardiac Metabolism Testing 
       7.5.    Cholesterol Testing 
       7.6.    Tumor/Cancer Markers Testing 
       7.7.    Blood Glucose Testing 
       7.8.    Urinalysis 
       7.9.    Hematology Testing 
       7.10.  Other Tests 

8.    Rapid Diagnostics Market, by End User 
       8.1.    Introduction 
       8.2.    Hospital & Clinics 
       8.3.    Diagnostic Laboratories 
       8.4.    Home Care/Self-testing 
       8.5.    Other End Users 

9.    Rapid Diagnostics Market, by Geography 
       9.1.    Introduction 
       9.2.    North America 
                 9.2.1.    U.S. 
                 9.2.2.    Canada 
       9.3.    Europe 
                 9.3.1.    Germany 
                 9.3.2.    U.K. 
                 9.3.3.    France 
                 9.3.4.    Italy 
                 9.3.5.    Spain 
                 9.3.6.    Rest of Europe (RoE) 
       9.4.    Asia-Pacific 
                 9.4.1.    China 
                 9.4.2.    Japan 
                 9.4.3.    India 
                 9.4.4.    Rest of Asia-Pacific (RoAPAC) 
       9.5.    Latin America 
       9.6.    Middle East & Africa 

10.    Competitive Landscape 
         10.1.    Introduction 
         10.2.    Key Growth Strategies 
         10.3.    Competitive Benchmarking 
         10.4.    Market Share Analysis (2021) 
                    10.4.1.    Abbott Laboratories (U.S.) 
                    10.4.2.    Becton, Dickinson and Company (U.S.) 
                    10.4.3.    F. Hoffmann-La Roche Ltd. (Switzerland) 

11.    Company Profiles (Business Overview, Financial Overview, Products Portfolio, Strategic Developments)
         11.1.    Abbott Laboratories  
         11.2.    Becton, Dickinson and Company (BD) 
         11.3.    Bio-Rad Laboratories, Inc. 
         11.4.    F. Hoffmann-La Roche Ltd 
         11.5.    ACON Laboratories, Inc. 
         11.6.    Creative Diagnostics 
         11.7.    Danaher Corporation 
         11.8.    Thermo Fisher Scientific Inc. 
         11.9.    BioMérieux S.A. 
         11.10.   Alfa Scientific Designs, Inc. 
         11.11.  BTNX Inc. 
         11.12.  Meridian Bioscience, Inc. 
         11.13.  Trinity Biotech plc 

12.    Appendix 
         12.1.    Questionnaire 
         12.2.    Available Customization 

List of Tables

Table 1    Rapid Diagnostics Market: Impact Analysis of Market Drivers (2022–2029) 
Table 2    Diabetes Prevalence in People Aged 65 Years and Above, by Region (2017 Vs. 2019 Vs. 2030) 
Table 3    Number of People Aged 65 Years and Above, by Region, 2019 Vs. 2050 (in Million) 
Table 4    Rapid Diagnostics Market: Impact Analysis of Market Restraints (2022–2029) 
Table 5    Percentage of Population Residing in Urban Areas (Emerging Countries) 
Table 6    Some of the Emergency Use Authorizations (EUAs) Granted for Rapid Diagnostics During the COVID-19 Pandemic 
Table 7    Global Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 8    Global Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 9    Global Rapid Diagnostic Kits Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 10    Global Professional Rapid Diagnostic Kits Market Size, by Country/Region, 2022–2029 (USD Million) 
Table 11    Prevalence of Diabetes, by Region, 2019–2045 (in Million) 
Table 12    Global OTC Rapid Diagnostic Kits Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 13    Key Companies Offering Test Readers/Analyzers 
Table 14    Global Rapid Diagnostics Equipment Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 15    Global Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 16    Global Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 17    Global Immunoassays Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 18    Recently Launched Lateral Flow Assays Kits for COVID-19 Testing 
Table 19    Key Companies Offering Lateral Flow Assays 
Table 20    Global Lateral Flow Assays Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 21    Key Companies Offering Serological Tests 
Table 22    Global Serological Tests Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 23    Global Other Immunoassays Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 24    Top Countries with the Highest Search Volume Index for Reverse Transcription-Polymerase Chain Reaction Tests (2020–2021) 
Table 25    Key Companies Offering Rapid Pcr Test Kits 
Table 26    Global Molecular Detection Tests Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 27    Global Other Rapid Diagnostic Platforms Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 28    Global Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 29    Global Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 30    Key Companies Offering Rapid Diagnostic Kits for Infectious Diseases Testing 
Table 31    Global Rapid Diagnostics Market Size for Infectious Diseases Testing, By Country/Region, 2020–2029 (USD Million) 
Table 32    Some of the Recently Launched and Approved Rapid Diagnostic Tests for COVID-19 Detection 
Table 33    Global Rapid Diagnostics Market Size for COVID-19 Testing, Country/Region, 2020–2029 (USD Million) 
Table 34    Global Rapid Diagnostics Market Size for Healthcare-Associated Infections (HAI) Testing, by Country/Region, 2020–2029 (USD Million) 
Table 35    Global Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 36    Global Rapid Diagnostics Market Size for Hepatitis Testing, by Country/Region, 2020–2029 (USD Million) 
Table 37    Global Rapid Diagnostics Market Size for Hepatitis B Testing, by Country/Region, 2020–2029 (USD Million) 
Table 38    Global Rapid Diagnostics Market Size for Hepatitis C Testing, by Country/Region, 2020–2029 (USD Million) 
Table 39    Incidence of Tropical Diseases (2019) 
Table 40    Global Rapid Diagnostics Market Size for Tropical Diseases Testing, By Country/Region, 2020–2029 (USD Million) 
Table 41    HIV Prevalence by Region (2020) 
Table 42    Global Rapid Diagnostics Market Size for HIV Testing, by Country/Region, 2020–2029 (USD Million) 
Table 43    Global Rapid Diagnostics Market Size for Respiratory Diseases Testing, By Country/Region, 2020–2029 (USD Million) 
Table 44    Global Rapid Diagnostics Market Size for Influenza Testing, by Country/Region, 2020–2029 (USD Million) 
Table 45    Global Rapid Diagnostics Market Size for Sexually Transmitted Diseases (STD) Testing, by Country/Region, 2020–2029 (USD Million) 
Table 46    Global Rapid Diagnostics Market Size for Other Infectious Diseases Testing, by Country/Region, 2020–2029 (USD Million) 
Table 47    Countries with High Fertility Rates 
Table 48    Key Companies Offering Rapid Diagnostic Kits for Pregnancy & Fertility Testing 
Table 49    Global Rapid Diagnostics Market Size for Pregnancy & Fertility Testing, by Country/Region, 2020–2029 (USD Million) 
Table 50    Key Companies Offering Rapid Diagnostic Kits for Cardiac Metabolism Testing 
Table 51    Global Rapid Diagnostics Market Size for Cardiac Metabolism Testing, by Country/Region, 2020–2029 (USD Million) 
Table 52    Global Rapid Diagnostics Market Size for Cholesterol Testing, by Country/Region, 2020–2029 (USD Million) 
Table 53    Key Companies Offering Tumor/Cancer Marker Testing Products 
Table 54    Global Rapid Diagnostics Market Size for Tumor/Cancer Markers Testing, By Country/Region, 2020–2029 (USD Million) 
Table 55    Number of People with Diabetes Aged 20–79 Years, by Region, 2019 Vs. 2030 Vs. 2045 (in Million) 
Table 56    Global Rapid Diagnostics Market Size for Blood Glucose Testing, By Country/Region, 2020–2029 (USD Million) 
Table 57    Global Rapid Diagnostics Market Size for Urinalysis, by Country/Region, 2020–2029 (USD Million) 
Table 58    Global Rapid Diagnostics Market Size for Hematology Testing, by Country/Region, 2020–2029 (USD Million) 
Table 59    Global Rapid Diagnostics Market Size for Other Tests, by Country/Region, 2020–2029 (USD Million) 
Table 60    Global Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 61    Global Rapid Diagnostics Market Size for Hospitals & Clinics, by Country/Region, 2020–2029 (USD Million) 
Table 62    Global Rapid Diagnostics Market Size for Diagnostic Laboratories, By Country/Region, 2020–2029 (USD Million) 
Table 63    Global Rapid Diagnostics Market Size for Home Care/Self-Testing, By Country/Region, 2020–2029 (USD Million) 
Table 64    Global Rapid Diagnostics Market Size for Other End Users, by Country/Region, 2020–2029 (USD Million) 
Table 65    Global Rapid Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 66    North America: Rapid Diagnostics Market Size, by Country, 2020–2029 (USD Million) 
Table 67    North America: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 68    North America: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 69    North America: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 70    North America: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 71    North America: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 72    North America: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million) 
Table 73    North America: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 74    North America: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 75    Rapid Diagnostic Kits Launched for Coronavirus Testing 
Table 76    U.S.: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 77    U.S.: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 78    U.S.: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 79    U.S.: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 80    U.S.: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 81    U.S.: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 82    U.S.: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 83    U.S.: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 84    Canada: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 85    Canada: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 86    Canada: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 87    Canada: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 88    Canada: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 89    Canada: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 90    Canada: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 91    Canada: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 92    Europe: Rapid Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 93    Europe: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 94    Europe: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 95    Europe: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 96    Europe: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 97    Europe: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 98    Europe: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 99    Europe: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 100    Europe: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 101    Recent Initiatives by the German Government to Tackle the Coronavirus Pandemic 
Table 102    Germany: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 103    Germany: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 104    Germany: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 105    Germany: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 106    Germany: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 107    Germany: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 108    Germany: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 109    Germany: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 110    U.K.: Number of Chlamydia Tests Conducted, 2018–2019 
Table 111    Recent Initiatives by the U.K. Government to Combat the COVID-19 Pandemic 
Table 112    U.K.: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 113    U.K.: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 114    U.K.: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 115    U.K.: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 116    U.K.: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 117    U.K.: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 118    U.K.: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 119    U.K.: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 120    France: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 121    France: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 122    France: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 123    France: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 124    France: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 125    France: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 126    France: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 127    France: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 128    Initiatives Undertaken by the Government of Italy to Tackle the COVID-19 Pandemic 
Table 129    Italy: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 130    Italy: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 131    Italy: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 132    Italy: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 133    Italy: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 134    Italy: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 135    Italy: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 136    Italy: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 137    Spain: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 138    Spain: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 139    Spain: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 140    Spain: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 141    Spain: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 142    Spain: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 143    Spain: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 144    Spain: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 145    Rest of Europe: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 146    Rest of Europe: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 147    Rest of Europe: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 148    Rest of Europe: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 149    Rest of Europe: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 150    Rest of Europe: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million) 
Table 151    Rest of Europe: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 152    Rest of Europe: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 153    Asia-Pacific: Rapid Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million) 
Table 154    Asia-Pacific: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 155    Asia-Pacific: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 156    Asia-Pacific: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 157    Asia-Pacific: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 158    Asia-Pacific: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 159    Asia-Pacific: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million) 
Table 160    Asia-Pacific: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 161    Asia-Pacific: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 162    China: Mass Testing Drives to Control the Spread of COVID-19 Infections 
Table 163    China: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 164    China: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 165    China: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 166    China: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 167    China: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 168    China: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 169    China: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 170    China: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 171    Japan: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 172    Japan: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 173    Japan: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 174    Japan: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 175    Japan: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 176    Japan: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 177    Japan: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 178    Japan: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 179    Recent Initiatives Launched by the Government of India to Combat the COVID-19 Pandemic 
Table 180    India: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 181    India: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 182    India: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 183    India: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 184    India: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 185    India: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 186    India: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 187    India: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 188    Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 189    Rest of Asia-Pacific: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 190    Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 191    Rest of Asia-Pacific: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 192    Rest of Asia-Pacific: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 193    Rest of Asia-Pacific: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 194    Rest of Asia-Pacific: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 195    Rest of Asia-Pacific: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 196    Latin America: Number of New HIV Cases, by Country (2019) 
Table 197    Latin America: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 198    Latin America: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 199    Latin America: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 200    Latin America: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 201    Latin America: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 202    Latin America: Rapid Diagnostics Market Size for Infectious Diseases Testing, By Type, 2020–2029 (USD Million) 
Table 203    Latin America: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 204    Latin America: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 205    Middle East & Africa: Rapid Diagnostics Market Size, by Product, 2020–2029 (USD Million) 
Table 206    Middle East & Africa: Rapid Diagnostic Kits Market Size, by Type, 2020–2029 (USD Million) 
Table 207    Middle East & Africa: Rapid Diagnostics Market Size, by Platform, 2020–2029 (USD Million) 
Table 208    Middle East & Africa: Immunoassays Market Size, by Type, 2020–2029 (USD Million) 
Table 209    Middle East & Africa: Rapid Diagnostics Market Size, by Application, 2020–2029 (USD Million) 
Table 210    Middle East & Africa: Rapid Diagnostics Market Size for Infectious Diseases Testing, by Type, 2020–2029 (USD Million) 
Table 211    Middle East & Africa: Rapid Diagnostics Market Size for Hepatitis Testing, by Type, 2020–2029 (USD Million) 
Table 212    Middle East & Africa: Rapid Diagnostics Market Size, by End User, 2020–2029 (USD Million) 
Table 213    Recent Developments, by Company, 2018–2021 

List of Figures

Figure 1    Research Process 
Figure 2    Key Secondary Sources 
Figure 3    Primary Research Techniques 
Figure 4    Key Executives Interviewed 
Figure 5    Breakdown of Primary Interviews (Supply-side & Demand-side) 
Figure 6    Market Size Estimation 
Figure 7    Global Rapid Diagnostics Market Size, By Product, 2022 Vs. 2022 (USD Million) 
Figure 8    Global Rapid Diagnostics Market Size, By Platform, 2022 Vs. 2029 (USD Million) 
Figure 9    Global Rapid Diagnostics Market Size, By Application, 2029 Vs. 2022 (USD Million) 
Figure 10    Global Rapid Diagnostics Market Size, By End User, 2022 Vs. 2029 (USD Million) 
Figure 11    Global Rapid Diagnostics Market, By Geography 
Figure 12    Market Dynamics 
Figure 13    Global Percentage Share of The Population Aged 65 and Above (2010–2020) 
Figure 14    U.S.: Hepatitis A Virus (HAV) Infections (2013–2020) 
Figure 15    EU Regulatory Pathway - IVDR 2017/746 
Figure 16    Chinese Medical Device Classification and Pre-Market Requirements for Rapid Diagnostic Devices 
Figure 17    Global Rapid Diagnostics Market Size, By Product, 2022 Vs. 2029 (USD Million) 
Figure 18    Global Rapid Diagnostics Market Size, By Platform, 2022 Vs. 2029 (USD Million) 
Figure 19    Reverse Transcription-Polymerase Chain Reaction: Global Search Volume Index 
Figure 20    Global Rapid Diagnostics Market Size, By Application, 2022 Vs. 2029 (USD Million) 
Figure 21    U.S.: Estimated Acute Hepatitis C Cases, 2011–2020 
Figure 22    Estimated Number of New Cancer Cases, By Region, 2020–2040 (in Million) 
Figure 23    Total Number of Accredited Testing Laboratories (Iso/Iec 17025), 2016–2020 
Figure 24    Prevalence of Diabetes Across The World (in Million) 
Figure 25    Global Rapid Diagnostics Market Size, By End User, 2022–2029 (USD Million) 
Figure 26    U.S.: Home Healthcare Spending, 2015–2026 (USD Million) 
Figure 27    Global Rapid Diagnostics Market Size, By Region, 2022 Vs. 2029 (USD Million) 
Figure 28    North America: Rapid Diagnostics Market Snapshot 
Figure 29    U.S.: Number of HIV-Positive Patients, 2017–2020 
Figure 30    Canada: Number of People Aged 65 Years and Above, 2016–2020 
Figure 31    Canada: Number of Inpatient Admissions in Acute-Care Hospitals, 2016–2020 (Per 1,00,000 Population) 
Figure 32    Europe: Rapid Diagnostics Market Snapshot 
Figure 33    U.K: Estimated Number of Cancer Cases, 2010–2030 (in Million) 
Figure 34   U.K.: Number of Diabetes and Urogenital, Blood, and Endocrine Disease Cases - DALYS (Disability-Adjusted Life Years), 2017 2020 (in Thousand) 
Figure 35    U.K.: Number of People Diagnosed With Sexually Transmitted Infections, 2018–2020 (in Thousand) 
Figure 36    France: Percentage of Population Aged 65 Years and Above, 2016–2020 
Figure 37    France: Prevalence of Chronic Diseases in People Aged 65 and Above (2019) 
Figure 38    Italy: Prevalence of Healthcare-Associated Infections in Acute-Care Wards, 2016–2019 
Figure 39    Italy: Ovarian Cancer Cases Diagnosed, 2018–2020 
Figure 40    Italy: Total Number of New Diagnostic Laboratories for BRCA1/2 Testing, 2010–2019 
Figure 41    Number of Hiv Tests Performed in Catalonia (Spain), 2014–2020 
Figure 42    Asia-Pacific: Rapid Diagnostics Market Snapshot 
Figure 43    China: Independent Medical Laboratories Market, 2015–2019 (USD Million) 
Figure 44    Japan: Percentage Growth in The Aging Population (2015–2021) 
Figure 45    Key Growth Strategies Adopted By Leading Players (2018–2021) 
Figure 46    Rapid Diagnostics Market: Competitive Benchmarking 
Figure 47    Market Share Analysis: Rapid Diagnostics Industry (2021) 
Figure 48    Abbott Laboratories: Financial Overview (2021) 
Figure 49    Becton, Dickinson and Company: Financial Overview (2021) 
Figure 50    Bio-Rad Laboratories, Inc.: Financial Overview (2021) 
Figure 51    F. Hoffmann-La Roche Ltd: Financial Overview (2021) 
Figure 52    Danaher Corporation: Financial Overview (2021) 
Figure 53    Thermo Fisher Scientific Inc.: Financial Overview (2021) 
Figure 54    BioMérieux S.A.: Financial Overview (2020) 
Figure 55    Meridian Bioscience, Inc.: Financial Overview (2021) 
Figure 56    Trinity Biotech plc: Financial Overview (2020) 

  Request Sample
Related Research